Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • BIOMARIN PHARMACEUTICAL INC Financial Overview

  • Income Statement: BMRN

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 296.49 M 121.58 M 174.91 M 58.99%
    Gross Profit 239.61 M 98.85 M 140.76 M 58.75%
    Net Income Before Extra Items/Preferred Div 30.83 M -15.80 M 46.63 M 151.26%
    Operating Income 39.76 M -57.29 M 97.04 M 244.10%
  • Cash Flow: BMRN

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 22.81 M 324.57 M -301.76 M -1,322.99%
    Net Cash Flow - Investing 19.08 M 151.00 M -131.92 M -691.51%
    Net Cash Flow/Operating Activities -9.18 M -34.50 M 25.32 M -275.97%
  • Balance Sheet: BMRN

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 906.70 M 815.28 M 91.42 M 10.08%
    Total Liabilities 630.02 M 627.55 M 2.47 M 0.39%
    Shareholders Equity 276.68 M 187.73 M 88.95 M 32.15%
  • Key Ratios / Statistics: BMRN

    • Valuation

      Price/Earnings (TTM) 61.38
      Price/Sales (TTM) 6.22
      Price/Book (MRQ) 5.99
      Price/Cash Flow (TTM) 18.19
    • Profitability

      Gross Margin 80.82
      Operating Margin 13.41
      Profit Margin 10.40
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 5.04
      Current Ratio (MRQ) 8.12
      Long Term Debt-to-Equity (MRQ) 163.59
    • Management Effectiveness

      Return on Equity (TTM) 12.74
      Return on Assets (TTM) 3.40
      Return on Investments (TTM) 5.69